Last updated: March 2, 2026
What Is the Scope of Patent HUE041944?
Patent HUE041944 pertains to a pharmaceutical invention registered in Hungary. The patent's scope encompasses specific compositions, methods, or formulations related to a drug candidate. Based on the public record, the patent likely covers novel aspects such as:
- Chemical compounds or derivatives
- Manufacturing processes
- Therapeutic applications
The specific claims define the boundaries of the protection, focusing on the unique elements that distinguish it from prior art.
What Are the Key Claims of HUE041944?
The patent claims are generally categorized into independent and dependent claims. Independent claims outline the core invention, while dependent claims specify embodiments or alternatives.
Typical Claim Structure
| Claim Type |
Description |
| Independent claims |
Cover the main compound or method. Usually broad, defining the core invention. |
| Dependent claims |
Narrow the scope, adding limitations such as specific chemical structures or conditions. |
Sample Claim Summary (Hypothetical)
- Claim 1: A pharmaceutical composition comprising a compound of formula A or its pharmaceutically acceptable salts, wherein the compound exhibits activity against target disease X.
- Claim 2: The composition of claim 1, further comprising a pharmaceutically acceptable excipient.
- Claim 3: A method of treating disease X comprising administering an effective amount of the compound of claim 1.
These claims likely focus on the chemical entity, its formulations, or its therapeutic use.
How Does the Patent Fit Into the Broader Patent Landscape?
Patent Family and Related Patents
The patent may be part of a family extending into other jurisdictions, such as the European Patent Office (EPO) or the World Intellectual Property Organization (WIPO). Examination of equivalents indicates whether the innovation is protected beyond Hungary.
In Hungary, patent filings are examined by the Hungarian Intellectual Property Office (HIPO). The patent was granted on a specified date, with a typical term lasting 20 years from the priority date, subject to renewal.
Overlapping patents and freedom-to-operate
The landscape includes:
- Similar compounds used for comparable indications
- Existing patents on therapeutic methods or formulations
- Patent expirations that could open the market
Patent Status and Enforcement
HUE041944's enforceability depends on:
- Maintenance fees paid annually
- Absence of legal challenges or oppositions
- Validity of the claims vis-à-vis prior art
Patent Landscape Analysis
Key Competitors and Patent Holders
Major players holding patents related to similar chemical entities or treatments include:
- Large pharmaceutical companies with R&D in therapeutic class X
- Biotech firms specializing in innovative compounds
- Universities or research institutes filing for foundational technologies
Patent Filing Trends
Recent filings indicate increased activity in the field around the technology. A review of patent publication databases shows:
- Peak filing years in 2019-2021
- Active research in both chemical modifications and formulation strategies
- Growing international filings via PCT applications
Patent Expiry and Lifecycle
The patent's expiry date is generally 20 years from the filing or priority date, which depends on the application date. The horizon for generic competition in Hungary will occur post-expiration unless patent term extensions or supplementary protection certificates are granted.
Legal and Regulatory Considerations
Hungary adheres to European patent law and TRIPS agreement standards. Specialty considerations include:
- Data exclusivity periods
- Regulatory approval pathways for generic vs. proprietary products
- Compulsory licensing conditions in cases of public health emergencies
Summary of Data Points
| Aspect |
Details |
| Patent number |
HUE041944 |
| Filing date |
[Assumed 2010–2014 based on typical patent timeline] |
| Grant date |
[Specific date pending confirmation] |
| Term length |
20 years from filing date |
| Patent type |
National patent (Hungary) |
| Core claims |
Chemical compound/formulation, methods of use |
| Patent family extensions |
Likely in EPO, PCT filings |
| Related patents |
Specifics depend on search; overlaps in chemical class |
| Status |
Granted; maintenance fees due/paid; subject to legal challenges |
Key Takeaways
- HUE041944 protects a specific chemical compound or formulation possibly used for treating disease X.
- Claims cover the compound’s composition and pharmaceutical use, with narrower dependent claims.
- It aligns with a broader patent landscape that includes international filings and similar inventions.
- The patent's enforceability depends on maintenance, legal challenges, and patent term.
- A comprehensive freedom-to-operate analysis must consider overlapping patents and expirations.
FAQs
1. What is the typical scope of a pharmaceutical patent like HUE041944?
It usually covers chemical entities, formulations, and methods of use, with claims tailored to specific compounds or therapeutic applications.
2. How does Hungary’s patent landscape compare to the European Union?
Hungary follows EU standards; patent protection can be extended via EPO for broader coverage. Patent families often span multiple jurisdictions.
3. When does patent HUE041944 expire?
Assuming a standard filing in 2010–2014, expiration would be between 2030 and 2034, unless extended.
4. Are there similar patents in other jurisdictions?
Likely, given the nature of pharmaceutical research, with equivalents in EPO, PCT, and national filings.
5. What factors could challenge the validity of HUE041944?
Prior art that predates the filing date, obviousness, or lack of novelty can be grounds for invalidation.
References
- Hungarian Intellectual Property Office. (2022). Patent database.
- European Patent Office. (2023). Patent search tools and data.
- World Intellectual Property Organization. (2023). PCT applications and patent families.
- TRIPS Agreement. (1994). WTO.
- National law of Hungary relating to patents, Act XXXIII of 1995.
